Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Colorectal Neoplasms

Free Subscription 20.04.2026 2 Am J Surg 1 Ann Oncol 11 Ann Surg Oncol 5 BMC Cancer 1 BMC Gastroenterol 1 Br J Cancer 2 Br J Surg 2 Cancer 2 Cancer Lett 2 Clin Cancer Res 2 Dis Colon Rectum 3 Eur J Cancer 1 Eur J Surg Oncol 1 Int J Cancer 1 J Clin Oncol 1 PLoS One 2 World J Surg

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. PAN S, Wang G
   A multidomain perioperative intervention improves postoperative recovery and clinical outcomes after abdominoperineal resection for low rectal cancer: A randomized controlled trial.
   Am J Surg. 2026;256:116931.
   PubMed         Abstract available
   
   
2. WANG G, Pan S
   Integrated psychosocial, sleep, and nutritional support improves postoperative recovery, immune modulation, and survival after curative resection for low rectal cancer: A randomized controlled trial.
   Am J Surg. 2026;256:116795.
   PubMed         Abstract available
   
   

   
   Ann Oncol

3. CREMOLINI C, Chalabi M, Elez E, Fassan M, et al
   Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
   Ann Oncol. 2026 Dec 31:S0923-7534(26)00108-0. doi: 10.1016/j.annonc.2026.
   PubMed        
   
   

   
   Ann Surg Oncol

4. MARTINEZ AE, DiBrito S
   ASO Author Reflections: Nationwide Disparities in Surgical Care of Colorectal Cancer Liver Metastases Persist Despite Advances in Liver-Directed Therapy.
   Ann Surg Oncol. 2026 Apr 16. doi: 10.1245/s10434-026-19636.
   PubMed        
   
   
5. SHIN JK, Kim HC, Lee WY, Yun SH, et al
   Calibrated Absolute Risk of Lymph-Node-Metastasis After Non-curative Endoscopic Resection of pT1 Colorectal Cancer.
   Ann Surg Oncol. 2026 Apr 13. doi: 10.1245/s10434-026-19582.
   PubMed         Abstract available
   
   
6. ALTAF A, Akabane M, Tong K, Khalil M, et al
   Interplay of Tumor Morphology and Biology with Postoperative Complications: Prognostic Implications After Resection of Colorectal Liver Metastasis.
   Ann Surg Oncol. 2026;33:3930-3942.
   PubMed         Abstract available
   
   
7. SWILLING AC, Chalise P, Al-Kasspooles M, Martin B, et al
   Volume-Outcome Relationships in Total Mesorectal Excision Quality and Grading: A National Cancer Database Study.
   Ann Surg Oncol. 2026;33:3806-3813.
   PubMed         Abstract available
   
   
8. MORITA S, Okabayashi K, Endo Y, Kurebayashi Y, et al
   Background Liver Fibrosis as a Microenvironmental Risk Factor for Intrahepatic Recurrence in Colorectal Liver Metastases.
   Ann Surg Oncol. 2026;33:3899-3909.
   PubMed         Abstract available
   
   
9. HARTLEY BW, Chen VW, Amin P, Iqbal A, et al
   Shifting Paradigm: Utilization and Outcomes with Neoadjuvant Chemotherapy for cT4 and cN2 Colon Cancers.
   Ann Surg Oncol. 2026;33:3849-3860.
   PubMed         Abstract available
   
   
10. VANDE KERCKHOVE FEC, Creemers DMJ, Banken E, Ketelaers SHJ, et al
    Locally Recurrent Rectal Cancer in the Lateral Compartment: Imaging Features and Association with Primary Tumour Characteristics.
    Ann Surg Oncol. 2026;33:3836-3848.
    PubMed         Abstract available
    
    
11. ALLIEVI N, Bayney S, Samuel MV, Tzivanakis A, et al
    Raised Serum Tumour Markers Predict Incomplete Cytoreduction, Disease-Free and Overall Survival in Patients with Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and HIPEC.
    Ann Surg Oncol. 2026;33:4153-4160.
    PubMed         Abstract available
    
    
12. CHANDRA P, Song Y, Seier K, Gonen M, et al
    The Effect of Pathologic Response to Preoperative Therapy on Margin Status and Outcomes After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2026;33:3875-3885.
    PubMed         Abstract available
    
    
13. PROCOPIO F, Memeo R, Del Fabbro D, Abdelhadi S, et al
    Oncological Adequacy of R1 Vascular Margin in Minimally Invasive Liver Surgery for Hepatocellular Carcinoma and Colorectal Liver Metastases: A Meta-analysis.
    Ann Surg Oncol. 2026;33:3886-3898.
    PubMed         Abstract available
    
    
14. ZHANG T, Shi L, Jian L, Jiang J, et al
    Clinical Benefit and Cost-Effectiveness of FOLFOX Versus LCCRT in Neoadjuvant Treatment for Patients with Locally Advanced Rectal Cancer: An Economic Analysis of the FOWARC and PROSPECT Trial.
    Ann Surg Oncol. 2026;33:3814-3826.
    PubMed         Abstract available
    
    

    
    BMC Cancer

15. HUANG YJ, Lee HH, Chen WM, Peng SM, et al
    Dose-response effect of statins on colorectal cancer risk in IBD: a nationwide cohort study.
    BMC Cancer. 2026 Apr 10. doi: 10.1186/s12885-026-15970.
    PubMed        
    
    
16. XI X, Zhang B
    RGD-modified hollow mesoporous nanoparticles loaded with cisplatin for antitumor therapy in colon cancer.
    BMC Cancer. 2026 Apr 11. doi: 10.1186/s12885-026-15923.
    PubMed        
    
    
17. LI Q, Chen Q, Chang J, Fu T, et al
    Metabolomics and proteomics analyses reveal the potiental mechanisms underlying colorectal cancer and chemotherapy targets.
    BMC Cancer. 2026 Apr 11. doi: 10.1186/s12885-026-15978.
    PubMed        
    
    
18. MOSTAFAVI-FINI HS, Moradi A, Gowdini E, Mohammadi R, et al
    Aspirin alters molecular crosstalk between prostaglandin, apoptosis, and invasion pathways in colorectal cancer.
    BMC Cancer. 2026 Apr 14. doi: 10.1186/s12885-026-15872.
    PubMed        
    
    
19. THET D, Areepium N, Rungruang C, Leelakanok N, et al
    Circulating vitamin D status and prognosis in colorectal cancer: a systematic review and meta-analysis with exploratory evidence on vitamin D receptor polymorphisms.
    BMC Cancer. 2026 Apr 16. doi: 10.1186/s12885-026-16026.
    PubMed        
    
    

    
    BMC Gastroenterol

20. HONG D, Dai J, Zhou X
    Molecular subtyping of colorectal cancer based on inositol metabolism identifies PLCG2 as a key prognostic biomarker.
    BMC Gastroenterol. 2026 Apr 15. doi: 10.1186/s12876-026-04789.
    PubMed        
    
    

    
    Br J Cancer

21. WANG Y, Song J, Song S, Zheng S, et al
    Notch signaling governs colorectal cancer metastasis via transcriptional control of TGF-beta effectors SMAD2/SMAD3.
    Br J Cancer. 2026 Apr 14. doi: 10.1038/s41416-026-03368.
    PubMed         Abstract available
    
    

    
    Br J Surg

22. TEMPERLEY HC, Coalter M, Creavin B, Jordan P, et al
    Evaluating the impact of GLP-1 receptor agonists in combination with total neoadjuvant therapy for locally advanced rectal cancer.
    Br J Surg. 2026;113:znag029.
    PubMed         Abstract available
    
    
23. WULLAERT L, van Leeuwen L, de Weerd V, Van M, et al
    Presurgical levels of circulating tumour DNA in patients with resectable chemotherapy-naive colorectal liver metastases: association with multiorgan recurrence and survival in the MIRACLE cohort.
    Br J Surg. 2026;113:znaf295.
    PubMed         Abstract available
    
    

    
    Cancer

24. TARASEWICZ M, Kazberuk M, Zbroch E, Markowski AR, et al
    Interpreting lifetime alcohol intake and colorectal cancer risk.
    Cancer. 2026;132:e70426.
    PubMed        
    
    
25. BARRY KH, Loftfield E
    Reply to "Interpreting lifetime alcohol intake and colorectal cancer risk".
    Cancer. 2026;132:e70424.
    PubMed        
    
    

    
    Cancer Lett

26. ZHANG S, Xu K, Du Y, Liu Z, et al
    Cross-species single-cell and spatial transcriptomic mapping reveals EFNA1-EPHA4-mediated stem-like epithelial-macrophage crosstalk driving colorectal cancer progression.
    Cancer Lett. 2026;649:218495.
    PubMed         Abstract available
    
    
27. SHU F, Zhang T, Chen X, Lu G, et al
    TGFbeta-SMAD2/3 signaling inhibits IRF2 to drive metastasis in KRAS-mutant colorectal Cancer.
    Cancer Lett. 2026 Apr 14:218507. doi: 10.1016/j.canlet.2026.218507.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

28. MORETTO R, Studiale V, Hyun SW, Vetere G, et al
    Circulating tumor DNA dynamics in patients with liver-limited metastatic colorectal cancer resected after first-line systemic treatment.
    Clin Cancer Res. 2026 Apr 13. doi: 10.1158/1078-0432.CCR-25-4641.
    PubMed         Abstract available
    
    
29. SINICROPE FA, Sharma N, Mohiuddin M, Saberzadeh-Ardestani B, et al
    Predictors of Immune Checkpoint Blockade Response in dMMR Colorectal Cancer Using an Integrated Immune-Enhanced Multi-Omics Platform.
    Clin Cancer Res. 2026 Apr 17. doi: 10.1158/1078-0432.CCR-25-3711.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

30. MURTHY JJ, Hernandez E, Groves E, Train K, et al
    Barriers to Surgical Colorectal Cancer Care in the Rural United States: A Scoping Review.
    Dis Colon Rectum. 2026 Apr 10. doi: 10.1097/DCR.0000000000004217.
    PubMed         Abstract available
    
    
31. KONEN J
    Research Perspective on "Barriers to Surgical Colorectal Cancer Care in the Rural United States: A Scoping Review".
    Dis Colon Rectum. 2026 Apr 10. doi: 10.1097/DCR.0000000000004256.
    PubMed        
    
    

    
    Eur J Cancer

32. RADEMAKER E, van der Woude JM, van den Berg R, Brohet RM, et al
    Colon cancer with a peritumoural abscess: Real-world evidence on prognostic and therapeutic implications of a disregarded entity.
    Eur J Cancer. 2026;240:116705.
    PubMed         Abstract available
    
    
33. GALANOS LJK, Elferink MAG, Lurvink RJ, Aarts MJ, et al
    Income, treatment patterns and outcome in patients with stage IV colorectal cancer.
    Eur J Cancer. 2026;240:116732.
    PubMed         Abstract available
    
    
34. DALAL G, Wright SJ, Malcomson L, Trenaman L, et al
    Quantifying preferences for watch-and-wait compared with surgery after a clinical complete response in locally advanced rectal cancer: A discrete choice experiment (PrefCoRe).
    Eur J Cancer. 2026;238:116589.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

35. SCARTON A, Kerkhoff TME, van Erning FN, Burger JWA, et al
    Conversion surgery after repeated intraperitoneal chemotherapy in unresectable peritoneal metastatic colorectal cancer: a narrative review of the literature.
    Eur J Surg Oncol. 2026;52:111803.
    PubMed         Abstract available
    
    

    
    Int J Cancer

36. MUSTAFA AM
    Comments on "Genetic Differences Between Primary Colorectal Cancer and Its Paired Synchronous and Metachronous Metastases".
    Int J Cancer. 2026 Apr 15. doi: 10.1002/ijc.70481.
    PubMed        
    
    

    
    J Clin Oncol

37. WU YL, Manji GA
    Circulating Tumor DNA for Minimal Residual Disease in Colon Cancer: Ready for Prime Time?
    J Clin Oncol. 2026 Apr 16:JCO2600369. doi: 10.1200/JCO-26-00369.
    PubMed        
    
    

    
    PLoS One

38. HERRERA-RAMIREZ A, Becerra-Quintana R, Yepes AF, Cardona-Galeano W, et al
    Novel benzofuran/pterostilbene hybrids trigger programmed cell death and impair migration in CRC cells.
    PLoS One. 2026;21:e0344602.
    PubMed         Abstract available
    
    

    
    World J Surg

39. LOHSIRIWAT V, Kaenla E, Ovartchaiyapong P
    Enhanced Recovery After Surgery Versus Conventional Care in Simultaneous Colorectal Resection and Hepatectomy for Synchronous Colorectal Liver Metastases.
    World J Surg. 2026;50:1069-1074.
    PubMed         Abstract available
    
    
40. ADDEO P, Canali G, Narita M, Marchitelli I, et al
    Two-Stage Hepatectomy for Bilobar Colorectal Liver Metastases: Outcomes According to Liver Transplant Selection Criteria.
    World J Surg. 2026;50:975-984.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum